The purpose of this resolution is to express support for a pricing strategy known as "most-favored-nation" drug pricing for prescription medications in the United States. This approach aims to ensure that American patients do not pay more for their medications than patients in other developed countries. The resolution highlights several key points. It notes that the U.S. spends significantly more on prescription drugs compared to other nations, with prices being nearly three times higher on average.